Conformationally restricted bicyclic analogs of somatostatin. 1978

D F Veber, and F W Holly, and W J Paleveda, and R F Nutt, and S J Bergstrand, and M Torchiana, and M S Glitzer, and R Saperstein, and R Hirschmann

A model for a biologically active conformation of somatostatin is proposed. This model is based primarily on the biological results obtained with novel bicyclic somatostatin analogs having a covalent bridge replacing the side chains of residues 5 and 10, 6 and 11, and 5 and 12, respectively, rather than on physical measurements on the hormone in solution. The high activity of an analog in which Phe6 and Phe11 are replaced by cystine provides evidence that these phenylalanines stabilize the biologically active conformer through "hydrophobic bonding" but do not directly interact with the receptor. The synthesis of the novel bicyclic analogs of somatostatin and the effects of these on the inhibition of secretion of insulin, glucagon, growth hormone, and gastric acid are described.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D010418 Pentagastrin A synthetic pentapeptide that has effects like gastrin when given parenterally. It stimulates the secretion of gastric acid, pepsin, and intrinsic factor, and has been used as a diagnostic aid. Acignost,Gastrin Pentapeptide,Peptavlon,Pentapeptide, Gastrin
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D005750 Gastric Juice The liquid secretion of the stomach mucosa consisting of hydrochloric acid (GASTRIC ACID); PEPSINOGENS; INTRINSIC FACTOR; GASTRIN; MUCUS; and the bicarbonate ion (BICARBONATES). (From Best & Taylor's Physiological Basis of Medical Practice, 12th ed, p651) Gastric Juices,Juice, Gastric,Juices, Gastric
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D006728 Hormones Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. Hormone,Hormone Receptor Agonists,Agonists, Hormone Receptor,Receptor Agonists, Hormone
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001681 Biological Assay A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. It includes virulence studies in animal fetuses in utero, mouse convulsion bioassay of insulin, quantitation of tumor-initiator systems in mouse skin, calculation of potentiating effects of a hormonal factor in an isolated strip of contracting stomach muscle, etc. Bioassay,Assay, Biological,Assays, Biological,Biologic Assay,Biologic Assays,Assay, Biologic,Assays, Biologic,Bioassays,Biological Assays

Related Publications

D F Veber, and F W Holly, and W J Paleveda, and R F Nutt, and S J Bergstrand, and M Torchiana, and M S Glitzer, and R Saperstein, and R Hirschmann
September 2011, Chemical reviews,
D F Veber, and F W Holly, and W J Paleveda, and R F Nutt, and S J Bergstrand, and M Torchiana, and M S Glitzer, and R Saperstein, and R Hirschmann
April 2009, Organic & biomolecular chemistry,
D F Veber, and F W Holly, and W J Paleveda, and R F Nutt, and S J Bergstrand, and M Torchiana, and M S Glitzer, and R Saperstein, and R Hirschmann
January 1985, Proceedings of the National Academy of Sciences of the United States of America,
D F Veber, and F W Holly, and W J Paleveda, and R F Nutt, and S J Bergstrand, and M Torchiana, and M S Glitzer, and R Saperstein, and R Hirschmann
June 2004, Bioorganic & medicinal chemistry letters,
D F Veber, and F W Holly, and W J Paleveda, and R F Nutt, and S J Bergstrand, and M Torchiana, and M S Glitzer, and R Saperstein, and R Hirschmann
January 1993, Advances in experimental medicine and biology,
D F Veber, and F W Holly, and W J Paleveda, and R F Nutt, and S J Bergstrand, and M Torchiana, and M S Glitzer, and R Saperstein, and R Hirschmann
August 1999, Bioorganic & medicinal chemistry letters,
D F Veber, and F W Holly, and W J Paleveda, and R F Nutt, and S J Bergstrand, and M Torchiana, and M S Glitzer, and R Saperstein, and R Hirschmann
October 1990, International journal of peptide and protein research,
D F Veber, and F W Holly, and W J Paleveda, and R F Nutt, and S J Bergstrand, and M Torchiana, and M S Glitzer, and R Saperstein, and R Hirschmann
June 1987, Die Pharmazie,
D F Veber, and F W Holly, and W J Paleveda, and R F Nutt, and S J Bergstrand, and M Torchiana, and M S Glitzer, and R Saperstein, and R Hirschmann
December 2005, Bioorganic & medicinal chemistry letters,
D F Veber, and F W Holly, and W J Paleveda, and R F Nutt, and S J Bergstrand, and M Torchiana, and M S Glitzer, and R Saperstein, and R Hirschmann
March 1991, International journal of peptide and protein research,
Copied contents to your clipboard!